Between the Biotech Waves
Celková doba trvání:
37 h 33 min
S2 E7: A Between the Biotech Waves Conversation with Bobby Gaspar
Between the Biotech Waves
58:30
S2 E6: A Between the Biotech Waves Conversation with Steve Paul
Between the Biotech Waves
56:05
S2 E5: A Between the Biotech Waves Conversation with Kent Rogers
Between the Biotech Waves
61:38
Between the Biotech Waves - Sound Bite - Bill Hicks Co-Chair Life Sciences Practice Mintz
Between the Biotech Waves
22:49
Between the Biotech Waves - Sound Bite - Paul Matteis Equity Analyst Stifel
Between the Biotech Waves
26:05
S2 E4: A Between the Biotech Waves Conversation with Dan Lynch
Between the Biotech Waves
61:00
S2 E3: A Between The Biotech Waves Conversation with Stan Crooke, Ionis & N-Lorem Founder
Between the Biotech Waves
64:50
S2 E2: A Between the Biotech Waves Conversation with Peter Barrett
Between the Biotech Waves
53:51
S2 Episode 1: A conversation with Matt Porteus
Between the Biotech Waves
54:32
Episode 35: A Between the Biotech Waves Conversation with Mike Curtis, President & CEO of eGenesis
Between the Biotech Waves
65:29
Episode 33: A Between the Biotech Waves conversation with Eliot Forster, xCEO of F-star Therapeutics
Between the Biotech Waves
64:37
Episode 32: The Triplet Therapeutics story, from concept to birth, life & death.
Between the Biotech Waves
105:49
Episode 31: A Between the Biotech Waves Conversation with Tim Yu
Between the Biotech Waves
55:34
Episode 30: A Between the Biotech Waves conversation with Barry Greene, CEO of Sage Therapeutics
Between the Biotech Waves
45:57
Episode 29: A Between the Biotech Waves conversation with Joel Marcus, Founder & Exec Chair of Alexandria Real Estate
Between the Biotech Waves
53:19
Episode 28 A Between the Biotech Waves Conversation with Rachel Meyers
Between the Biotech Waves
57:39
Episode 27 A Between the Biotech Waves Conversation with Aoife Brennan, CEO of Synlogic
Between the Biotech Waves
66:59
Episode 26: A Between the Biotech Waves conversation with Drew Weissman
Between the Biotech Waves
57:08
Episode 25: A Between the Biotech Waves conversation with Rodolphe Barrangou, the Todd R Klaenhammer Distinguished Professor at NC State University.
Between the Biotech Waves
60:19
Episode 23: A Between the Biotech Waves conversation with Jim Birchenough, Vice Chair of Wells Fargo Biopharmaceutical Inv Banking
Between the Biotech Waves
56:51
Episode 24: A Between the Biotech Waves conversation with John Hoffman, managing director & head of healthcare equity capital markets at Credit Suisse
Between the Biotech Waves
51:38
A Between the Biotech Waves Conversation with Jeremy Levin, Chair & CEO of Ovid Therapeutics
Between the Biotech Waves
71:32
Episode 21 A Between the Biotech Waves conversation with Laksh Aithani Co-founder & CEO of Charm Therapeutics
Between the Biotech Waves
47:37
Episode 20: A Between the Biotech Waves conversation with Tom Barnes, CEO of ORNA Therapeutics
Between the Biotech Waves
53:50
Episode 19: A Between the Biotech Waves Conversation with JeanFrancois Formela, Partner at Atlas Venture & multi-biotech company founder
Between the Biotech Waves
50:11
Episode 18: A Between the Biotech Waves conversation with Ram Aiyer, CEO of RNA base editing company Korro Bio
Between the Biotech Waves
67:43
Episode 17: A Between the Biotech Waves conversation with Regina Jorgensen, Director of the Maria Mitchell Observatory.
Between the Biotech Waves
67:01
Episode 16: A Between the Biotech Waves conversation with Abraham Heifets CEO of Atomwise
Between the Biotech Waves
60:18
Episode 15: A Between the Biotech Waves Conversation with Rodger Novak and Shaun Foy, co-founders with Emmanuelle Charpentier of CRISPR Therapeutics
Between the Biotech Waves
67:22
Episode 14: A Between the Biotech Waves Conversation with Paul Matteis, Managing Director of Biotechnology Equity Research at Stifel
Between the Biotech Waves
60:57
Episode 13: A Between the Biotech Waves Conversation with Vic Myer, President and CSO at Chroma Medicine
Between the Biotech Waves
52:07
Episode 11: A Between the Biotech Waves conversation with Prof Robert Langer. In this episode we discuss nanoparticle delivery systems and the evolution of drug discovery.
Between the Biotech Waves
51:13
Episode 12: A Between the Biotech Waves conversation with Geoff Meacham, Managing Director of Equity Research at Banc of America covering Biotechnology and Major Pharmaceuticals in the US.
Between the Biotech Waves
53:27
Episode 9: A Between the Biotech Waves Conversation with Yaron Werber, MD of Healthcare Biotechnology at Cowen.
Between the Biotech Waves
52:28
Episode 10: A Between the Biotech Waves Conversation with Eric Topol focusing on COVID & AI in healthcare
Between the Biotech Waves
49:51
Episode 7 A conversation with John Hoffman Managing Director & head of Healthcare ECM at Credit Suisse
Between the Biotech Waves
51:19
Episode 8 John Leonard CEO of Intellia Therapeutics
Between the Biotech Waves
49:54
A Between The Biotech Waves Conversation With William Hicks, Co-Chair of Securities & Capital Markets Mintz Levin
Between the Biotech Waves
53:03
A Between The Biotech Waves Conversation With Jim Birchenough, Vice Chair Wells Fargo Biopharmaceutical Investment Banking
Between the Biotech Waves
41:08
A Between The Biotech Waves Conversation With Sumit Khedekar, Head of Healthcare of the Americas Investment Banking at Citi
Between the Biotech Waves
51:51
